Can Elliott's Stake Revitalize Align Technology?

Elliott Investment Management has acquired a significant stake in Align Technology, the maker of Invisalign, to enhance the company's stock value after a substantial decline since 2021. Align's stock, which peaked at $729.92 amid increased demand for cosmetic procedures during the pandemic, closed at $172.41 recently. Analysts from Barclays Plc note signs of stabilization in dental markets, projecting Align's stock to trade at 12 times its earnings before interest, taxes, depreciation, and amortization, compared to the current 10 times. Elliott's involvement follows its history of strategic investments in healthcare companies, aiming for market revitalization.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.